Sign inJoin waitlistJoin the waitlist

Kartik Konduri

Physician · Texas Oncology

Credentials: · · · ·

History

Texas Oncology
Present

Baylor University Medical Center
2001–2003
Rush-Presbyterian St Lukes Medical Center-Westlake Hospital Medicine Residency Program
1995–1998
University of Delhi
University of Delhi
1989–1993

Research

Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer
Journal of Clinical Oncology · 2009 · 172 citations
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
Case report · Cancer Discovery · 2016 · First of 24 authors · 104 citations
BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib
Case report · Lung Cancer · 2014 · Last of 4 authors · Corresponding · 66 citations

DS
David Spigel
3 papers
RJ
Robert Jotte
3 papers
Corey Langer
2 papers
Jared Weiss
2 papers
MS
Mark Socinski
2 papers
MS
Matei Socoteanu
2 papers
SS
Shirley Shiller
2 papers · 1 as a fellow
AG
Ajeet Gajra
1 paper
AS
Alison Schram
1 paper
AA
Alwin Alias
1 paper · 1 as a resident
AW
Andrew Whiteley
1 paper · 1 as a fellow
AM
Anton Melnyk
1 paper

Clinical trials

Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC
Principal investigator · Completed · Phase 1, Phase 2
Syndax Pharmaceuticals
2008–2012
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Site PI · Recruiting · Phase 1, Phase 2
Genprex, Inc.
2024–2028